nach oben

AIDS and Behavior

Erschienen in:

31.07.2020 | Original Paper

Substance Use Stigma, Avoidance Coping, and Missed HIV Appointments Among MSM Who Use Substances

verfasst von: Abigail W. Batchelder, Jacklyn D. Foley, Megan R. Wirtz, Kenneth Mayer, Conall O’Cleirigh

Erschienen in: AIDS and Behavior | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Men who have sex with men (MSM) living with HIV who use substances have multiple stigmatized identities. Theory suggests that internalization of stigma may elicit avoidance behaviors associated with these stigmas, potentially resulting in suboptimal engagement in HIV care. We investigated interrelationships between internalized stigmas related to HIV, sexual orientation, and substance use; avoidance coping; and missed HIV appointments among 202 MSM living with HIV who use substances. Neither HIV nor sexual orientation-related internalized stigmas were associated with missed appointments, however, internalized substance use stigma (SUS) was associated (OR 1.47, 95% CI 1.15, 1.87). The relationship between internalized SUS and missed appointments was partially accounted for by avoidance coping (b = 0.12; bootstrap 95% CI 0.02, 0.25). To better understand the role of SUS, we assessed relationships between enacted and anticipated SUS and missed appointments (OR 2.08, 95% CI 1.52, 2.84 and OR 1.44, 95% CI 1.10, 1.88, respectively). Avoidance coping fully accounted for the relationship between anticipated SUS and missed appointments (b = 0.12; 95% CI 0.02, 0.25). Results suggest that avoidance strategies to manage anticipated SUS may result in substance using MSM forgoing HIV care appointments.

HIV and gay and bisexual men | HIV by group | HIV/AIDS | CDC. 2018. https://www.cdc.gov/hiv/group/msm/index.html. Accessed 26 July 2019.

HIV treatment as prevention. 2019. https://www.cdc.gov/hiv/risk/art/index.html

Kay ES, Batey DS, Mugavero MJ. The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future. AIDS Res Ther. 2016;13(1):35.PubMedPubMedCentral

Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. J Am Med Assoc. 2009;301(22):2380–2.

Dodd PJ, Garnett GP, Hallett TB. Examining the promise of HIV elimination by “test and treat” in hyperendemic settings. AIDS Lond Engl. 2010;24(5):729–35.

Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet Lond Engl. 2009;373(9657):48–57.

Eisinger RW, Dieffenbach CW, Fauci AS. HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable. JAMA. 2019;321(5):451–2.PubMed

Mugavero MJ, Westfall AO, Cole SR, et al. Beyond core indicators of retention in HIV care: missed clinic visits are independently associated with all-cause mortality. Clin Infect Dis. 2014;59(10):1471–9.PubMedPubMedCentral

Reveles KR, Juday TR, Labreche MJ, et al. Comparative value of four measures of retention in expert care in predicting clinical outcomes and health care utilization in HIV patients. PLoS ONE. 2015;10(3):e0120953.PubMedPubMedCentral

10.

White JM, Gordon JR, Mimiaga MJ. The role of substance use and mental health problems in medication adherence among HIV-infected MSM. LGBT Health. 2014;1(4):319–22.PubMed

11.

Gonzalez A, Barinas J, O’Cleirigh C. Substance use: impact on adherence and HIV medical treatment. Curr HIV/AIDS Rep. 2011;8(4):223–34.PubMed

12.

Cochran SD, Ackerman D, Mays VM, Ross MW. Prevalence of non-medical drug use and dependence among homosexually active men and women in the US population. Addict Abingdon Engl. 2004;99(8):989–98.

13.

Cochran SD, Mays VM. Burden of psychiatric morbidity among lesbian, gay, and bisexual individuals in the California Quality of Life Survey. J Abnorm Psychol. 2009;118(3):647–58.PubMedPubMedCentral

14.

Amirkhanian YA, Kelly JA, DiFranceisco WJ, et al. Predictors of HIV care engagement, antiretroviral medication adherence, and viral suppression among people living with HIV infection in St. Petersburg. Russia. AIDS Behav. 2018;22(3):791–9.PubMed

15.

Bauman LJ, Braunstein S, Calderon Y, et al. Barriers and facilitators of linkage to HIV primary care in New York City. J Acquir Immune Defic Syndr. 2013;64(Suppl 1):S20–26.PubMedPubMedCentral

16.

Lancaster KE, Hetrick A, Jaquet A, et al. Substance use and universal access to HIV testing and treatment in sub-Saharan Africa: implications and research priorities. J Virus Erad. 2018;4(Suppl 2):26–322.PubMedPubMedCentral

17.

Sprague C, Simon SE. Understanding HIV care delays in the US south and the role of the social-level in HIV care engagement/retention: a qualitative study. Int J Equity Health. 2014;8(13):28.

18.

Woodward B, Person A, Rebeiro P, Kheshti A, Raffanti S, Pettit A. Risk prediction tool for medical appointment attendance among HIV-infected persons with unsuppressed viremia. AIDS Patient Care STDs. 2015;29(5):240–7.PubMedPubMedCentral

19.

Meyer IH. Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence. Psychol Bull. 2003;129(5):674–97.PubMedPubMedCentral

20.

Hatzenbuehler ML. How does sexual minority stigma “get under the skin”? A psychological mediation framework Psychol Bull. 2009;135(5):707–30.PubMed

21.

Hatzenbuehler ML. The social environment and suicide attempts in lesbian, gay, and bisexual youth. Pediatrics. 2011;127(5):896–903.PubMedPubMedCentral

22.

Korthuis PT, Edelman EJ. Substance use and the HIV care continuum: important advances. Addict Sci Clin Pract. 2018;13(1):13.PubMedPubMedCentral

23.

Strathdee SA, Stockman JK. Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions. Curr HIV/AIDS Rep. 2010;7(2):99–106.PubMedPubMedCentral

24.

Arici C, Ripamonti D, Maggiolo F, et al. Factors associated with the failure of HIV-positive persons to return for scheduled medical visits. HIV Clin Trials. 2002;3(1):52–7.PubMed

25.

Rajabiun S, Mallinson RK, McCoy K, et al. “Getting Me Back on Track”: the role of outreach interventions in engaging and retaining people living with HIV/AIDS in medical care. AIDS Patient Care STDs. 2007;21(s1):S-20–S-29.

26.

Hall BJ, Sou K-L, Beanland R, et al. Barriers and facilitators to interventions improving retention in HIV care: a qualitative evidence meta-synthesis. AIDS Behav. 2017;21(6):1755–67.PubMedPubMedCentral

27.

Committee on the Science of Changing Behavioral Health Social Norms, Board on Behavioral, Cognitive, and Sensory Sciences, Division of Behavioral and Social Sciences and Education, National Academies of Sciences, Engineering, and Medicine. Ending discrimination against people with mental and substance use disorders. Washington, D.C.: National Academies Press (US); 2016. https://www.ncbi.nlm.nih.gov/books/NBK384915/. Accessed 4 Dec 2019

28.

Livingston JD, Milne T, Fang ML, Amari E. The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction. 2012;107(1):39–50.PubMedPubMedCentral

29.

van Boekel LC, Brouwers EPM, van Weeghel J, Garretsen HFL. Healthcare professionals’ regard towards working with patients with substance use disorders: comparison of primary care, general psychiatry and specialist addiction services. Drug Alcohol Depend. 2014;134:92–8.PubMed

30.

Rao H, Mahadevappa H, Pillay P, Sessay M, Abraham A, Luty J. A study of stigmatized attitudes towards people with mental health problems among health professionals. J Psychiatr Ment Health Nurs. 2009;16(3):279–84.PubMed

31.

Gwadz M, de Guzman R, Freeman R, et al. Exploring how substance use impedes engagement along the HIV care continuum: a qualitative study. Front Public Health. 2016. https://www.frontiersin.org/articles/10.3389/fpubh.2016.00062/full. Accessed 26 July 2019

32.

Stringer KL, Marotta P, Baker E, et al. Substance use stigma and antiretroviral therapy adherence among a drug-using population living with HIV. AIDS Patient Care STDs. 2019;33(6):282–93.PubMedPubMedCentral

33.

Helms CB, Turan JM, Atkins G, et al. Interpersonal mechanisms contributing to the association between HIV-related internalized stigma and medication adherence. AIDS Behav. 2017;21(1):238–47.PubMedCentral

34.

Luoma JB, Kulesza M, Hayes SC, Kohlenberg B, Larimer M. Stigma predicts residential treatment length for substance use disorder. Am J Drug Alcohol Abuse. 2014;40(3):206–12.PubMedPubMedCentral

35.

Pachankis JE, Rendina HJ, Restar A, Ventuneac A, Grov C, Parsons JT. A minority stress—emotion regulation model of sexual compulsivity among highly sexually active gay and bisexual men. Health Psychol. 2015;34(8):829–40.PubMed

36.

Sayles JN, Ryan GW, Silver JS, Sarkisian CA, Cunningham WE. Experiences of social stigma and implications for healthcare among a diverse population of HIV positive adults. J Urban Health. 2007;84(6):814.PubMedPubMedCentral

37.

Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13(6):1160.PubMedPubMedCentral

38.

Link BG. Understanding labeling effects in the area of mental disorders: an assessment of the effects of expectations of rejection. Am Sociol Rev. 1987;52(1):96–112.

39.

Sayles JN, Hays RD, Sarkisian CA, Mahajan AP, Spritzer KL, Cunningham WE. Development and psychometric assessment of a multidimensional measure of internalized HIV stigma in a sample of HIV-positive adults. AIDS Behav. 2008;12(5):748–58.PubMedPubMedCentral

40.

Herek GM, Cogan JC, Gillis JR, Glunt EK. Correlates of internalized homophobia in a community sample of lesbians and gay men. J Gay Lesbian Med Assn. 1998;2(1):17–25.

41.

Smith LR, Earnshaw VA, Copenhaver MM, Cunningham CO. Substance use stigma: reliability and validity of a theory-based scale for substance-using populations. Drug Alcohol Depend. 2016;1(162):34–433.

42.

Carver CS. You want to measure coping but your protocol’s too long: consider the Brief COPE. Int J Behav Med. 1997;4(1):92–100.PubMed

43.

Ironson G, Balbin E, Stuetzle R, et al. Dispositional optimism and the mechanisms by which it predicts slower disease progression in HIV: proactive behavior, avoidant coping, and depression. Int J Behav Med. 2005;12(2):86–97.PubMedPubMedCentral

44.

Batchelder AW, Safren SA, Coleman JN, et al. Indirect effects from childhood sexual abuse severity to PTSD: the role of avoidance coping. J Interpers Violence. 2018;22:886260518801030.

45.

Hayes AF. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. 2nd ed. New York, NY: Guilford Press; 2017.

46.

Glick SN, Golden MR. Persistence of racial differences in attitudes toward homosexuality in the United States. J Acquir Immune Defic Syndr. 2010;55(4):516–23.PubMedPubMedCentral

47.

Howarth A, Apea V, Michie S, et al. REACH: a mixed-methods study to investigate the measurement, prediction and improvement of retention and engagement in outpatient HIV care. Southampton (UK): NIHR Journals Library; 2017. Health Services and Delivery Research. https://www.ncbi.nlm.nih.gov/books/NBK425236/. Accessed 4 Dec 2019.

48.

Reif S, Wilson E, McAllaster C, Pence B. The relationship of HIV-related stigma and health care outcomes in the US deep south. AIDS Behav. 2019;23(S3):242–50.PubMed

49.

van Boekel LC, Brouwers EPM, van Weeghel J, Garretsen HFL. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1–2):23–35.PubMed

50.

Safren SA, Blashill AJ, O’Cleirigh CM. Promoting the sexual health of MSM in the context of comorbid mental health problems. AIDS Behav. 2011;15(S1):30–4.

51.

Stotts AL, Northrup TF. The promise of third-wave behavioral therapies in the treatment of substance use disorders. Curr Opin Psychol. 2015;2:75–81.PubMedPubMedCentral

52.

O’Cleirigh C, Safren S. Optimizing the effects of stress management interventions in HIV. Health Psychol Off J Div Health Psychol Am Psychol Assoc. 2008;27(3):297–301.

53.

Batchelder AW, Moskowitz JT, Jain J, Cohn M, Earle MA, Carrico AW. A novel technology-enhanced internalized stigma and shame intervention for HIV-positive persons with substance use disorders. Cogn Behav Pract. 2020;27(1):55–69.PubMed

54.

Bazzi AR, Fergus KB, Stephenson R, et al. A dyadic behavioral intervention to optimize same sex male couples’ engagement across the HIV care continuum: development of and protocol for an innovative couples-based approach (partner steps). JMIR Res Protoc. 2016;5(3):e168.PubMedPubMedCentral

55.

Levy ME, Watson CC, Wilton L, et al. Acceptability of a mobile smartphone application intervention to improve access to HIV prevention and care services for black men who have sex with men in the District of Columbia. Digit Cult Educ. 2015;7(2):169–91.PubMedPubMedCentral

56.

Stephenson R, Suarez NA, Garofalo R, et al. Project Stronger Together: protocol to test a dyadic intervention to improve engagement in HIV care among sero-discordant male couples in three US cities. JMIR Res Protoc. 2017;6(8):e170.PubMedPubMedCentral

Titel: Substance Use Stigma, Avoidance Coping, and Missed HIV Appointments Among MSM Who Use Substances
verfasst von: Abigail W. Batchelder
Jacklyn D. Foley
Megan R. Wirtz
Kenneth Mayer
Conall O’Cleirigh
Publikationsdatum: 31.07.2020
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 5/2021
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-020-02982-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2021

Competence to Consent to Oral and Injectable PrEP Trials Among Adolescent Males Who Have Sex with Males

A Structural Equation Model of the Effect of Masculinity and Avoidant Coping on Gay and Bisexual Men’s Sexual Risk-Taking

Lifetime Burden of Incarceration and Violence, Internalized Homophobia, and HIV/STI Risk Among Black Men Who Have Sex with Men in the HPTN 061 Study

Marketing of Tenofovir Disoproxil Fumarate (TDF) Lawsuits and Social Media Misinformation Campaigns’ Impact on PrEP Uptake Among Gender and Sexual Minority Individuals

Brief Report: HIV Testing and Risk Among Justice-Involved Youth